Using clinical baseline data collected from participants and ELISA results for IGHG3, ISG15, and ZNF683, we randomly divided the samples into training and testing groups to construct prediction models for patients with AITD hyperthyroidism and hypothyroidism. Here, IGHG3 is linked to hyperthyroidism.